View Future GrowthBon Natural Life 過去の業績過去 基準チェック /06Bon Natural Lifeの収益は年間平均-24.5%の割合で減少していますが、 Chemicals業界の収益は年間 増加しています。収益は年間1.4% 0.06%割合で 増加しています。主要情報-24.54%収益成長率-32.75%EPS成長率Chemicals 業界の成長12.93%収益成長率0.062%株主資本利益率-3.53%ネット・マージン-10.68%前回の決算情報30 Sep 2025最近の業績更新Full year 2025 earnings released: US$0.72 loss per share (vs US$4.37 profit in FY 2024) Jan 23First half 2025 earnings released Sep 30Full year 2024 earnings released: EPS: US$0.17 (vs US$5.03 in FY 2023) Jan 28First half 2024 earnings released: US$0.008 loss per share (vs US$2.38 profit in 1H 2023) Nov 25First half 2024 earnings released: US$0.008 loss per share (vs US$2.38 profit in 1H 2023) Oct 01First half 2023 earnings released: EPS: US$0.24 (vs US$0.30 in 1H 2022) Sep 15すべての更新を表示Recent updatesBon Natural Life Limited Announces Development of Apple Bio-Electronic MaskFeb 20Full year 2025 earnings released: US$0.72 loss per share (vs US$4.37 profit in FY 2024) Jan 23Returns On Capital Signal Tricky Times Ahead For Bon Natural Life (NASDAQ:BON)Dec 23Bon Natural Life Limited Unveils Kombucha-Inspired ProductDec 11Investor sentiment deteriorates as stock falls 18% Nov 18New minor risk - Share price stability Nov 17There's No Escaping Bon Natural Life Limited's (NASDAQ:BON) Muted RevenuesOct 15First half 2025 earnings released Sep 30Investor sentiment improves as stock rises 30% Sep 10Bon Natural Life Limited Announces Identification of Promising Weight-Managing Compounds from Tea Via AI-Powered New Drug R&D PlatformSep 03New minor risk - Financial data availability Aug 17Bon Natural Life Limited Launches AI-Powered New Drug Research and DevelopmentJul 30Investor sentiment improves as stock rises 28% Jul 08Revenues Working Against Bon Natural Life Limited's (NASDAQ:BON) Share PriceJul 08New major risk - Shareholder dilution Jul 07Bon Natural Life Limited (NasdaqCM:BON) announces an Equity Buyback for $1 million worth of its shares.Jun 03BON Natural Life Limited Debuts Broccoli-Derived Sleep Wellness Line, Reshaping the Sleep Health Market Through Innovative TechnologyMay 15Bon Natural Life Limited Announces Receipt of Nasdaq Delisting NotificationsMay 03Bon Natural Life Limited Announces Unlocking Broccoli's Nutritional Power: Advanced Delivery System for Glucoraphanin ActivationApr 09Bon Natural Life Limited Announces Revolutionary Postbiotic Blood Sugar Solution Nears Patent LaunchMar 20Bon Natural Life Limited has completed a Composite Units Offering in the amount of $11.999998 million.Mar 19Investor sentiment improves as stock rises 26% Mar 17New major risk - Share price stability Mar 14Investor sentiment deteriorates as stock falls 17% Feb 24Lacklustre Performance Is Driving Bon Natural Life Limited's (NASDAQ:BON) 27% Price DropFeb 06Bon Natural Life (NASDAQ:BON) Could Be Struggling To Allocate CapitalFeb 04Full year 2024 earnings released: EPS: US$0.17 (vs US$5.03 in FY 2023) Jan 28Investor sentiment deteriorates as stock falls 16% Jan 22Bon Natural Life Limited (NASDAQ:BON) Held Back By Insufficient Growth Even After Shares Climb 27%Dec 13Bon Natural Life Limited (NASDAQ:BON) Held Back By Insufficient Growth Even After Shares Climb 27%Dec 13Investor sentiment improves as stock rises 22% Dec 12First half 2024 earnings released: US$0.008 loss per share (vs US$2.38 profit in 1H 2023) Nov 25Bon Natural Life Limited has filed a Follow-on Equity Offering in the amount of $26 million.Nov 21Investor sentiment deteriorates as stock falls 17% Oct 09First half 2024 earnings released: US$0.008 loss per share (vs US$2.38 profit in 1H 2023) Oct 01New minor risk - Profit margin trend Sep 29New minor risk - Financial data availability Aug 27Investor sentiment improves as stock rises 20% Jun 14Investor sentiment deteriorates as stock falls 18% Jun 06New major risk - Share price stability May 28Investor sentiment improves as stock rises 23% May 22Bon Natural Life Limited's (NASDAQ:BON) Shares Not Telling The Full StoryApr 30High number of new and inexperienced directors Apr 30Bon Natural Life Limited, Annual General Meeting, Mar 09, 2024Feb 25Bon Natural Life Limited announced delayed 20-F filingJan 31Fewer Investors Than Expected Jumping On Bon Natural Life Limited (NASDAQ:BON)Jan 27Bon Natural Life Limited Announces Advancement in SulforaphaneNov 30Bon Natural Life's (NASDAQ:BON) Returns Have Hit A WallNov 13High number of new and inexperienced directors Nov 01Bon Natural Life Limited Announces Appointment of Jing Chen and Zhixiang Gao as Additional Independent DirectorsOct 13New major risk - Shareholder dilution Oct 06First half 2023 earnings released: EPS: US$0.24 (vs US$0.30 in 1H 2022) Sep 15Returns on Capital Paint A Bright Future For Bon Natural Life (NASDAQ:BON)Aug 15New minor risk - Financial data availability Aug 13Bon Natural Life Limited Receives Nasdaq Notification Regarding Independent Board RequirementJul 08Bon Natural Life Receives NASDAQ Notification Regarding Minimum Bid DeficiencyJun 22Bon Natural Life Limited Launches Three New Cruciferous Vegetable-Based Powder DrinksJun 03Why We Like The Returns At Bon Natural Life (NASDAQ:BON)May 01Bon Natural Life Limited to Report Fiscal Year 2022 Results on Feb 10, 2023Feb 08Bon Natural Life Limited announced delayed 20-F filingFeb 01Investor sentiment deteriorates as stock falls 16% Jan 23The Returns At Bon Natural Life (NASDAQ:BON) Aren't GrowingJan 16Investor sentiment improved over the past week Jan 05Investor sentiment improved over the past week Nov 28Less than half of directors are independent Nov 16Investor sentiment deteriorated over the past week Nov 01Investor sentiment deteriorated over the past week Oct 10Bon Natural Life Limited Provides Update on Its Expansion ProjectOct 01Investor sentiment improved over the past week Sep 14Less than half of directors are independent Sep 03Investor sentiment improved over the past week Aug 22We Think That There Are Some Issues For Bon Natural Life (NASDAQ:BON) Beyond Its Promising EarningsAug 08Investor sentiment improved over the past week Aug 08First half 2022 earnings released Aug 02Bon Natural Life GAAP EPS of $0.30, revenue of $13.7M Aug 01Bon Natural Life Limited to Report Q2, 2022 Results on Aug 01, 2022Jul 29Investor sentiment deteriorated over the past week Jul 01Bon Natural Life Limited Announces Board ChangesJul 01Bon Natural Life (NASDAQ:BON) Is Experiencing Growth In Returns On CapitalJun 24Bon Natural Life Limited Introduces New Powder Drink for Anti-H. Pylori and Digestive HealthJun 17Investor sentiment deteriorated over the past week May 27Investor sentiment improved over the past week May 03Bon Natural Life Limited Adds New Multi-Functional Health Supplements to Product LineApr 22Investor sentiment deteriorated over the past week Apr 06A Piece Of The Puzzle Missing From Bon Natural Life Limited's (NASDAQ:BON) 41% Share Price ClimbMar 05Investor sentiment improved over the past week Mar 04Investor sentiment improved over the past week Feb 07Full year 2021 earnings: Revenues and EPS in line with analyst expectations Feb 03Bon Natural Life Limited to Report Fiscal Year 2021 Results on Jan 31, 2022Jan 30Investor sentiment deteriorated over the past week Jan 10Investor sentiment deteriorated over the past week Nov 22Investor sentiment deteriorated over the past week Oct 28Investor sentiment deteriorated over the past week Oct 13Investor sentiment deteriorated over the past week Sep 28Investor sentiment improved over the past week Sep 09First half 2021 earnings released: EPS US$0.40 (vs US$0.30 in 1H 2020) Aug 21収支内訳Bon Natural Life の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史NasdaqCM:BON 収益、費用、利益 ( )USD Millions日付収益収益G+A経費研究開発費30 Sep 2519-25131 Mar 252213131 Dec 242313130 Sep 242404231 Mar 242623131 Dec 232843130 Sep 233053030 Jun 233053031 Mar 233063031 Dec 223063030 Sep 223062030 Jun 222962031 Mar 222752031 Dec 212652030 Sep 212551030 Jun 212441031 Mar 212341031 Dec 202031030 Sep 201832030 Jun 201731031 Mar 201531031 Dec 191631130 Sep 191632130 Sep 1811011質の高い収益: BONは現在利益が出ていません。利益率の向上: BONは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: BONは利益が出ておらず、過去 5 年間で損失は年間24.5%の割合で増加しています。成長の加速: BONの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: BONは利益が出ていないため、過去 1 年間の収益成長をChemicals業界 ( 0.1% ) と比較することは困難です。株主資本利益率高いROE: BONは現在利益が出ていないため、自己資本利益率 ( -3.53% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日(UTC時間)企業分析2026/05/03 18:07終値2026/05/01 00:00収益2025/09/30年間収益2025/09/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Bon Natural Life Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Hunter DiamondDiamond Equity Research LLC
Bon Natural Life Limited Announces Identification of Promising Weight-Managing Compounds from Tea Via AI-Powered New Drug R&D PlatformSep 03
Bon Natural Life Limited (NasdaqCM:BON) announces an Equity Buyback for $1 million worth of its shares.Jun 03
BON Natural Life Limited Debuts Broccoli-Derived Sleep Wellness Line, Reshaping the Sleep Health Market Through Innovative TechnologyMay 15
Bon Natural Life Limited Announces Unlocking Broccoli's Nutritional Power: Advanced Delivery System for Glucoraphanin ActivationApr 09
Bon Natural Life Limited Announces Revolutionary Postbiotic Blood Sugar Solution Nears Patent LaunchMar 20
Bon Natural Life Limited has completed a Composite Units Offering in the amount of $11.999998 million.Mar 19
Bon Natural Life Limited (NASDAQ:BON) Held Back By Insufficient Growth Even After Shares Climb 27%Dec 13
Bon Natural Life Limited (NASDAQ:BON) Held Back By Insufficient Growth Even After Shares Climb 27%Dec 13
Bon Natural Life Limited Announces Appointment of Jing Chen and Zhixiang Gao as Additional Independent DirectorsOct 13
We Think That There Are Some Issues For Bon Natural Life (NASDAQ:BON) Beyond Its Promising EarningsAug 08
A Piece Of The Puzzle Missing From Bon Natural Life Limited's (NASDAQ:BON) 41% Share Price ClimbMar 05